INmune Bio INMB is preparing to release its quarterly earnings on Thursday, 2025-03-27. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect INmune Bio to report an earnings per share (EPS) of $-0.56.

INmune Bio bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Earnings History Snapshot

Last quarter the company missed EPS by $0.10, which was followed by a 3.25% increase in the share price the next day.

Here's a look at INmune Bio's past performance and the resulting price change:

Tracking INmune Bio's Stock Performance

Shares of INmune Bio were trading at $8.86 as of March 25. Over the last 52-week period, shares are down 33.23%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.

To track all earnings releases for INmune Bio visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.